Key words
COVID-19
dermatology
Moderna
mRNA
Pfizer
public health
registry
SARS-CoV-2
vaccine
vaccine reaction
delayed hypersensitivity
delayed inflammatory reaction
zoster
shingles
delayed large local reaction
pityriasis rosea
local injection site reaction
erythromelalgia
urticaria
morbilliform
pernio
chilblains
vesicular
erythema multiforme
filler
vasculitis
Comentários